1. Home
  2. Stocks
  3. Indramedco Share Price

Indraprastha Medical Corporation Share Price

Healthcare Small Cap

₹437.10 +17.75 (4.23%)

05 Nov, 2024 22:00

SIP TrendupStart SIP in INDRAMEDCO

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹414
  • High
  • ₹440
  • 52 Week Low
  • ₹155
  • 52 Week High
  • ₹484
  • Open Price₹421
  • Previous Close₹419
  • Volume411,453

Investment Returns

  • Over 1 Month + 3.22%
  • Over 3 Month + 63.43%
  • Over 6 Month + 66.04%
  • Over 1 Year + 157.27%
SIP Lightning

Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!

Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 27.1
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 4,007
  • P/B Ratio
  • 8.4
  • Average True Range
  • 22.48
  • EPS
  • 13.6
  • Dividend Yield
  • 1
  • MACD Signal
  • -2.36
  • RSI
  • 55.78
  • MFI
  • 52.34

Indraprastha Medical Corporation Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations349.82347.86314.73306.46317.00
Total Income From Operations349.82347.86314.73306.46317.00
P/L Before Interest, Excpt. Items & Tax58.5261.2043.1241.5444.50
P/L Before Exceptional Items & Tax56.9359.5941.5640.6743.65
P/L After Tax from Ordinary Activities42.4044.7731.1729.4432.85
Net Profit/Loss For the Period42.4044.7731.1729.4432.85
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,204.061,064.95
Revenue From Operations [Net]1,204.061,064.95
Total Operating Revenues1,244.701,098.67
Total Revenue1,261.591,108.70
Total Expenses1,095.48991.52
Profit/Loss Before Tax166.11117.18
Profit/Loss For The Period123.9686.15
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity200.15144.47
Net Cash Used In Investing Activity-158.43-107.91
Net Cash Used in Finance Activity-32.38-26.04
Net Inc/Dec In Cash And Equivalent9.3410.52
Cash And Equivalent End Of Year61.6052.26
IndicatorMar 24Mar 23
Total Share Capital91.6791.67
Total Non-Current Liabilities80.0646.06
Total Current Liabilities165.42129.63
Total Capital And Liabilities723.24555.14
Total Non-Current Assets415.26332.06
Total Current Assets307.98223.08
Total Assets723.24555.14
Indicator20242023
EBIT Margin (%)13.6711.05
Return On Capital Employed (%)30.5028.54
Return On Equity (%)25.9422.70
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)52.1241.39
Indicator20242023
EBIT Margin (%)13.6711.05
Return On Capital Employed (%)30.5028.54
Return On Equity (%)25.9422.70
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)52.1241.39

Indraprastha Medical Corporation Technicals

EMA & SMA

Current Price
₹437.10
+ 17.75 (4.23%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹420.94
  • 50 Day
  • ₹408.68
  • 100 Day
  • ₹368.02
  • 200 Day
  • ₹307.99

Resistance and Support

430.22 Pivot Speed
  • R3 473.33
  • R2 456.67
  • R1 446.88
  • S1 420.43
  • S2 403.77
  • S3 393.98

Is Indraprastha Medical Corporation Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indraprastha Medical Corporation Ltd. operates the prestigious Indraprastha Apollo Hospitals in New Delhi, providing world-class healthcare services. It offers a wide range of medical specialties, advanced diagnostics, and state-of-the-art facilities for patients from India and abroad. Indraprastha Med. (Nse) Corp. has an operating revenue of Rs. 1,318.87 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 13% is healthy, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 45% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-30 Quarterly Results
2024-08-05 Quarterly Results
2024-05-17 Audited Results & Final Dividend
2024-02-06 Quarterly Results
2023-11-03 Quarterly Results

Indraprastha Medical Corporation F&O

Indraprastha Medical Corporation Shareholding Pattern

51%
2.66%
2.64%
0%
30.11%
13.59%
  • NSE Symbol
  • INDRAMEDCO
  • BSE Symbol
  • 532150
  • Managing Director
  • Mr. Pattabhiraman Shivakumar
  • ISIN
  • INE681B01017

Indraprastha Medical Corporation FAQs

Indraprastha Medical Corporation share price is ₹437 As on 05 November, 2024 | 21:46

The Market Cap of Indraprastha Medical Corporation is ₹4007 Cr As on 05 November, 2024 | 21:46

The P/E ratio of Indraprastha Medical Corporation is 27.1 As on 05 November, 2024 | 21:46

The PB ratio of Indraprastha Medical Corporation is 8.4 As on 05 November, 2024 | 21:46

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.